2 min.Read

Is Pharma’s Business Model like McDonald’s? Are Pharma Managers Graduates in Hamburgerology?

December 3, 2021

Is Pharma's business model like McDonald's? Doing things over & over again without innovation?

McDonald's is famous for its Hamburger University, a training facility at the McDonald's Corporation global headquarters in Chicago, Illinois. It instructs high-potential restaurant managers in restaurant management.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Topics

Pharma CEO Roundtable – Engaging Doctors – Physical, Digital and Hybrid: Translating Strategy into Action

Going Digital – What Indian Pharma C-Suite has to Say

Is Pharma’s Business Model like McDonald’s? Are Pharma Managers Graduates in Hamburgerology?

Free Membership Required

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Topics

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

Pharmacy of the World Pricing Paradox

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

MedicinMan Pharma Pulse: August 2026

Related Articles

Will Mounjaro Disrupt Existing Therapy Areas Like Cardiology?

The Anatomy of a Miscalculation: Why Maharashtra’s Homeopathic Prescription Policy Defies Global Medical Standards

What ChrysCapital’s Takeover Of Novartis India Really Means

Lifetime Value of a Patient: Why Indian Pharma must Transition from Product-centric Selling to Patient-centric Healthcare

Sun Pharma’s Genius Dealmaking — Dilip Shanghvi, Indian Pharma’s Shrewdest Businessman

Company

Headlines

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

The $1.5 Billion Question in Hyderabad: Orbicular, Peptides and the PE Re-Rating of Indian Complex Generics

Medical Reps—Lessons From The West: The Old Model is Dead

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

Newsletter